Extra copies of EGFR gene signal poor prognosis for vulvar cancer
Wednesday, October 29, 2008 - 09:10
in Health & Medicine
A genetic fingerprint identified in patients with a gynaecologic cancer may reveal candidates for targeted therapy. In a study in the journal Gynecologic Oncology, investigators from the Massachusetts General Hospital (MGH) Obstetrics and Gynaecology Service report that women with vulvar carcinoma whose tumours have extra copies of the epidermal growth factor receptor (EGFR) gene are at increased risk of dying from their cancer...